Infection Risk With Vedolizumab Vs Anti-TNFα
Researchers sought to compare the incidence of Clostridioides difficile infection [...]
ulcerative colitis
Infection Risk With Vedolizumab Vs Anti-TNFα
| Categories: ibs, ulcerative-colitis
Researchers sought to compare the incidence of Clostridioides difficile infection (CDI) and cytomegalovirus colitis (CMVC) in patients with ulcerative colitis (UC) receiving either vedolizumab or […]
Etrolizumab, Adalimumab, or Placebo in Patients With Ulcerative Colitis
In the HIBISCUS I trial, researchers found etrolizumab improved rate [...]
Identifying Medications Associated With Microscopic Colitis
Citing inconsistent findings in previous studies, researchers further investigated if [...]
Metabolic Changes in the Colons of Patients With Ulcerative Colitis
In a study published in PLOS ONE, researchers evaluated metabolic [...]
